Moderna (MRNA) Revenue — Quarter Ended Jun 30, 2025
Moderna reported revenue growth in the current quarter compared to the immediately preceding quarter. However, revenue was lower than the same quarter one year earlier.
Key takeaway
Quarter ended Jun 30, 2025 · FY2025 Q2
Moderna reported revenue growth in the current quarter compared to the immediately preceding quarter. However, revenue was lower than the same quarter one year earlier.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$142M
Revenue reported for this quarter.
Quarter-over-quarter
+31.5%
Change from the immediately preceding quarter.
Year-over-year
-41.1%
Change from the comparable year-ago quarter.
Trailing four quarters
$3.1B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Sep 30, 2024 | $1.9B | +1.7% |
| Dec 31, 2024 | $966M | -65.6% |
| Mar 31, 2025 | $108M | -35.3% |
| Jun 30, 2025 | $142M | -41.1% |
Revenue performance
Revenue increased from the prior quarter, reversing a recent downward trend.
Quarterly comparison
While revenue rose sequentially, it was significantly lower than the amount reported in the same quarter of the prior year.
What to watch
The sequential improvement may not indicate a sustained trend, given the substantial year-over-year decline.